Register Interest

Pictor Ltd

Pictor has developed a novel COVID-19 antibody diagnostic.  The patented test can differentiate antibody positive people who have been either vaccinated or infected.  This will assist in border control and in developing countries, the identification of individuals who will only require one vaccine shot.  The company is raising $7 million with the goal of achieving a trade sale before 2023.